14 David Abrams Teva- Pharmaceutical Industries Ltd. - ADR Trades
David Abrams acquired 6 Million Teva- Pharmaceutical Industries Ltd. - ADR shares worth $77.2 Million. That's 2.39% of their equity portfolio (11th largest holding). The first Teva- Pharmaceutical Industries Ltd. - ADR trade was made in Q3 2011. Since then David Abrams bought shares four more times and sold shares on nine occasions. The investor's estimated purchase price is $116 Million, resulting in a loss of 33%.
Avg closing price
Price range
Sold 24.7% shares (-1.97 Million shares)
Q4 2023
Avg closing price
$9.34
Price range
$8.12
-
$10.63
Sold 50.0% shares (-7.97 Million shares)
Q1 2023
Avg closing price
$9.89
Price range
$8.36
-
$11.37
Sold 33.3% shares (-7.97 Million shares)
Q4 2022
Avg closing price
$8.73
Price range
$7.95
-
$9.48
Sold 0.6% shares (-147 Thousand shares)
Q3 2022
Avg closing price
$8.84
Price range
$6.86
-
$11.21
Increased shares by 33.2% (+6 Million shares)
Q3 2019
Avg closing price
$7.66
Price range
$6.16
-
$9.60
Sold 2.6% shares (-476 Thousand shares)
Q1 2019
Avg closing price
$17.63
Price range
$15.58
-
$20.01
Sold 5.1% shares (-1 Million shares)
Q4 2018
Avg closing price
$20.50
Price range
$14.59
-
$23.84
Sold 1.1% shares (-221 Thousand shares)
Q3 2018
Avg closing price
$23.22
Price range
$21.06
-
$25.65
Sold 8.7% shares (-1.88 Million shares)
Q4 2017
Avg closing price
$15.04
Price range
$11.23
-
$19.10
New holding (+21.6 Million shares)
Q3 2017
Avg closing price
$22.50
Price range
$15.41
-
$33.31
Sold -2.56 Million shares
Q3 2013
Avg closing price
$39.00
Price range
$37.43
-
$41.27
Increased shares by 8.8% (+206 Thousand shares)
Q4 2012
Avg closing price
$39.92
Price range
$36.95
-
$42.52
Increased shares by 8.5% (+184 Thousand shares)
Q4 2011
Avg closing price
$39.84
Price range
$35.85
-
$42.72
New holding (+2.17 Million shares)
Q3 2011
Avg closing price
$41.82
Price range
$35.26
-
$49.47
